Literature DB >> 19870361

RENAL DAMAGE FOLLOWING THE INGESTION OF A DIET CONTAINING AN EXCESS OF INORGANIC PHOSPHATE.

E M Mackay1, J Oliver.   

Abstract

The addition of an excess of inorganic phosphate in the form of orthophosphoric acid, acid, basic or neutral sodium or potassium phosphate to the diet of albino rats results in the development of an interesting and permanent renal lesion. The phosphate renal lesion is characterized by a necrosis of the cells of the convoluted tubules commencing at the terminal end, followed by a regeneration of atypical epithelium and calcification of the necrotic debris that fills the tubules. The entire outer stripe of the outer zone of the medulla is transformed into a zone of distorted structures and there is an increase in the interstitial connective tissue. The adjoining cortex is also involved with cystic dilatation of tubules and collapse. Such areas may reach the free surface of the organ and produce a retracted scar. In the gross the kidneys are enlarged and firm on section with a pebbled surface produced by numerous scars. The maximum changes in the kidney structure are reached after some 15 days although necrosis of the convoluted tubule cells is evident after a single day of phosphate feeding. The renal structure is not restored to its normal form when the excess of phosphate is removed from the diet.

Entities:  

Year:  1935        PMID: 19870361      PMCID: PMC2133223          DOI: 10.1084/jem.61.3.319

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  THE HISTOGENESIS OF CHRONIC URANIUM NEPHRITIS WITH ESPECIAL REFERENCE TO EPITHELIAL REGENERATION.

Authors:  J Oliver
Journal:  J Exp Med       Date:  1915-05-01       Impact factor: 14.307

  1 in total
  26 in total

1.  Phosphate toxicity: a stealth biochemical stress factor?

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Med Mol Morphol       Date:  2015-11-18       Impact factor: 2.309

Review 2.  Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism.

Authors:  Makoto Kuro-o
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

Review 3.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

Review 4.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

5.  Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification.

Authors:  Neil J Paloian; Elizabeth M Leaf; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2016-03-09       Impact factor: 10.612

6.  The experimental induction of parathyroid hyperplasia in rats, and the use of toluidine blue O for in vivo identification of parathyroid tissue.

Authors:  R H Whitaker
Journal:  Calcif Tissue Res       Date:  1971

Review 7.  [The effects of disorders of electrolyte balance on the structure and function of the kidneys].

Authors:  W Herms
Journal:  Klin Wochenschr       Date:  1967-12-01

8.  [Nephrocalcinosis and alkaline kidney phosphatase].

Authors:  O von Deimling
Journal:  Klin Wochenschr       Date:  1968-10-15

9.  Dietary phosphate restriction attenuates polycystic kidney disease in mice.

Authors:  Faith Omede; Shiqin Zhang; Cassandra Johnson; Emily Daniel; Yan Zhang; Timothy A Fields; Joseph Boulanger; Shiguang Liu; Ishfaq Ahmed; Shahid Umar; Darren Paul Wallace; Jason R Stubbs
Journal:  Am J Physiol Renal Physiol       Date:  2019-11-04

10.  High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats.

Authors:  Masaki Mizuno; Jere H Mitchell; Scott Crawford; Chou-Long Huang; Naim Maalouf; Ming-Chang Hu; Orson W Moe; Scott A Smith; Wanpen Vongpatanasin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-05-11       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.